WANBURY240.65

Wanbury Limited

· Pharma & Health
₹ CrorePeersAHCLANUHPHRBAJAJHCARETHEMISMEDZIMLABLINCOLNSIGACHIVALIANTLABMcap ₹789 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Last 12M
30/06/2025
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation12.413.013.3
+ Finance Costs21.429.237.0
+ Interest Income-0.4-0.40.0
+ Fair Value (Gains) / Losses0.0-0.0-0.1
+ Share-based Payments0.9-0.51.1
+ Unrealised FX (Gain) / Loss0.1-0.3-0.2
+ Other Non-cash Items0.0-25.60.0
+ Other — Cash Effects are Investing / Financing0.0-0.2-2.0
+ Other Reconciling Items2.81.10.0
Changes in Working Capital
+ Inventories27.7-14.0-1.7
+ Trade Receivables — Current-5.3-20.3-25.4
+ Other Financial Assets — Current0.30.0-1.1
+ Other Financial Assets — Non-current-0.3-0.2-0.1
+ Other Current Assets4.9-1.60.5
+ Other Non-current Assets0.0-0.3-1.0
+ Trade Payables — Current-26.65.0-22.1
+ Other Financial Liabilities — Current-3.7-32.10.1
+ Other Financial Liabilities — Non-current0.00.0-1.6
+ Other Current Liabilities-5.4-6.0-0.6
+ Provisions — Current-0.30.40.5
+ Provisions — Non-current1.90.61.4
Cash from Operating Activities
Profit Before Tax (per I/S)-10.356.329.642.1
+ Total Adjustments (incl. Working Capital)30.3-52.2-2.0
Cash from Operations (pre-tax)20.04.227.6
+ Interest Paid — Operating0.00.00.7
+ Other Inflows / (Outflows) — Operating0.00.0-0.4
+ Income Taxes Paid0.20.20.4
Cash from Operating Activities19.84.026.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.017.449.0
+ Disp of Fixed Assets0.13.60.4
+ Disp of Intangible Assets3.10.00.0
+ Disp of Investment Property0.00.00.2
+ Interest Received — Investing0.30.20.6
+ Other Inflows / (Outflows) — Investing-12.3-3.0-3.4
Cash from Investing Activities-8.8-16.6-51.2
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.0
+ Proceeds from Other Equity Instruments0.06.00.0
+ Proceeds from Debentures / Notes / Bonds0.095.00.0
+ Proceeds from Borrowings0.00.063.8
+ Repayment of Borrowings12.50.00.0
+ Payment of Lease Liabilities3.03.13.4
+ Payment of Finance Lease Liabilities0.048.6
+ Interest Paid16.534.734.7
Cash from Financing Activities-32.014.625.7
Net Changes in Cash (pre-FX)-21.01.90.7
Net Changes in Cash-21.01.90.7
Closing Cash1.53.4
Reference Items
EBITDA23.270.076.388.0
EBITDA Margin %4.6412.1612.7313.98
Free Cash Flow (CFO − Capex)19.8-13.4-22.9-22.9
Free Cash Flow to Equity-2.35.6
Free Cash Flow per Basic Share6.04-4.10-7.00-7.00
Cash Flow to Net Income-1.900.070.85
Cash Paid for Taxes0.20.20.4
Cash Paid for Interest16.534.734.7
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.